Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Sell
10,681
-1,982
-16% -$207K 0.29% 62
2026
Q1
$983K Buy
12,663
+1,242
+11% +$97.2K 0.25% 80
2025
Q4
$880K Buy
+11,421
New +$847K 0.21% 77
2024
Q3
Sell
-4,531
Closed -$215K 133
2024
Q2
$215K Sell
4,531
-1,034
-19% -$49.1K 0.08% 138
2024
Q1
$278K Sell
5,565
-327
-6% -$16.3K 0.11% 118
2023
Q4
$298K Buy
5,892
+1,482
+34% +$75.7K 0.12% 106
2023
Q3
$249K Sell
4,410
-6,024
-58% -$325K 0.12% 98
2023
Q2
$164K Buy
+10,434
New +$513K 0.08% 114
2022
Q2
Sell
-20,460
Closed -$1.14M 52
2022
Q1
$1.14M Buy
20,460
+744
+4% +$42.1K 0.91% 31
2021
Q4
$1.25M Buy
19,716
+3,554
+22% +$203K 0.77% 34
2021
Q3
$880K Buy
16,162
+1,612
+11% +$90.4K 0.53% 43
2021
Q2
$771K Buy
+14,550
New +$765K 0.53% 45

Other funds holding CSCO

Prostatis Group's CSCO Position: Q2 2026 in Review

Prostatis Group reduced its Cisco (CSCO) stake by 16% in Q2 2026, selling an estimated $207K and leaving 10,681 shares worth $1.25M. The position accounts for 0.29% of the portfolio, ranked #62.

Prostatis Group first reported a position in CSCO in Q2 2021 and has held it in 12 quarters since. 4,066 funds tracked by Wall St. Rank hold CSCO as of Q2 2026.

  • Prostatis Group held 10,681 shares of Cisco worth $1.25M as of Q2 2026.
  • Prostatis Group sold 1,982 Cisco shares in Q2 2026, an estimated $207K.
  • Cisco made up 0.29% of Prostatis Group's portfolio in Q2 2026, its #62 holding.
  • Prostatis Group first reported a position in Cisco in Q2 2021 and has held it in 12 quarters since.
  • 4,066 funds tracked by Wall St. Rank held Cisco as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.